223 related articles for article (PubMed ID: 25695524)
1. Cross-platform meta-analysis of multiple gene expression profiles identifies novel expression signatures in acquired anthracycline-resistant breast cancer.
Lee YS; Ryu SW; Bae SJ; Park TH; Kwon K; Noh YH; Kim SY
Oncol Rep; 2015 Apr; 33(4):1985-93. PubMed ID: 25695524
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel therapeutic target genes in acquired lapatinib-resistant breast cancer by integrative meta-analysis.
Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Choi JD; Kwon K; Jang CS; Ro YT; Noh YH; Kim SY
Tumour Biol; 2016 Feb; 37(2):2285-97. PubMed ID: 26361955
[TBL] [Abstract][Full Text] [Related]
3. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance.
Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY
Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174
[TBL] [Abstract][Full Text] [Related]
4. Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes.
Wang H; Yu Y; Chen C; Wang Q; Huang T; Hong F; Zhu L
Mol Med Rep; 2015 Aug; 12(2):2503-10. PubMed ID: 25955318
[TBL] [Abstract][Full Text] [Related]
5. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
Liang B; Li C; Zhao J
Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
[TBL] [Abstract][Full Text] [Related]
6. Screening of the prognostic targets for breast cancer based co-expression modules analysis.
Liu H; Ye H
Mol Med Rep; 2017 Oct; 16(4):4038-4044. PubMed ID: 28731166
[TBL] [Abstract][Full Text] [Related]
7. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of aggressive behavior of breast cancer via an integrated gene regulatory network.
Yang X; Jia M; Li Z; Lu S; Qi X; Zhao B; Wang X; Rong Y; Shi J; Zhang Z; Xu W; Gao Y; Zhang S; Yu G
J Cancer Res Ther; 2014; 10(4):1013-8. PubMed ID: 25579546
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
Peng C; Ma W; Xia W; Zheng W
Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
[TBL] [Abstract][Full Text] [Related]
10. Identified differently expressed genes in renal cell carcinoma by using multiple microarray datasets running head: differently expressed genes in renal cell carcinoma.
Cheng Y; Hong M; Cheng B
Eur Rev Med Pharmacol Sci; 2014; 18(7):1033-40. PubMed ID: 24763884
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of biomarkers and their functions for Lapatinib-resistant breast cancer.
Zhang L; Huang Y; Zhuo W; Zhu Y; Zhu B; Chen Z
Med Oncol; 2017 May; 34(5):89. PubMed ID: 28393315
[TBL] [Abstract][Full Text] [Related]
12. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
13. Integrative meta-analysis of multiple gene expression profiles in acquired gemcitabine-resistant cancer cell lines to identify novel therapeutic biomarkers.
Lee YS; Kim JK; Ryu SW; Bae SJ; Kwon K; Noh YH; Kim SY
Asian Pac J Cancer Prev; 2015; 16(7):2793-800. PubMed ID: 25854364
[TBL] [Abstract][Full Text] [Related]
14. Identification of differently expressed genes in leukemia using multiple microarray datasets.
Zhang ZY; Xu RQ; Guo TJ; Zhang M; Li DX; Lu XY
Genet Mol Res; 2014 Dec; 13(4):10482-9. PubMed ID: 25511031
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiling and bioinformatics analysis of dysregulated microRNAs in vinorelbine-resistant breast cancer cells.
Zhong S; Ma T; Zhang X; Lv M; Chen L; Tang J; Zhao J
Gene; 2015 Feb; 556(2):113-8. PubMed ID: 25445394
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of Transcriptomics and Genetic Alterations Identifies Potential Mechanisms Underlying Anthracycline Therapy Resistance in Breast Cancer.
Liu Z; Gao J; Gu R; Shi Y; Hu H; Liu J; Huang J; Zhong C; Zhou W; Yang Y; Gong C
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551262
[TBL] [Abstract][Full Text] [Related]
17. Identification of genes and pathways related to breast cancer metastasis in an integrated cohort.
Wang L; Mo C; Wang L; Cheng M
Eur J Clin Invest; 2021 Jul; 51(7):e13525. PubMed ID: 33615456
[TBL] [Abstract][Full Text] [Related]
18. Combined Analysis of ChIP Sequencing and Gene Expression Dataset in Breast Cancer.
Liu P; Jiang W; Zhou S; Gao J; Zhang H
Pathol Oncol Res; 2017 Apr; 23(2):361-368. PubMed ID: 27654269
[TBL] [Abstract][Full Text] [Related]
19. Potential biomarkers and latent pathways for vasculitis based on latent pathway identification analysis.
Zhou T; Zhang Y; Wu P; Sun Q; Guo Y; Yang Y
Int J Rheum Dis; 2014 Jul; 17(6):671-8. PubMed ID: 24867262
[TBL] [Abstract][Full Text] [Related]
20. Protein-protein interaction network and mechanism analysis of hepatitis C.
Tang Y; Tang Q; Dong C; Li X; Zhang Z; An F
Genet Mol Res; 2015 Mar; 14(1):2069-79. PubMed ID: 25867353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]